nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—SLC22A2—nephron—focal segmental glomerulosclerosis	0.129	0.312	CbGeAlD
Amantadine—DDC—nephron tubule—focal segmental glomerulosclerosis	0.0338	0.0818	CbGeAlD
Amantadine—DDC—kidney—focal segmental glomerulosclerosis	0.0297	0.0719	CbGeAlD
Amantadine—DDC—cortex of kidney—focal segmental glomerulosclerosis	0.0289	0.07	CbGeAlD
Amantadine—SLC22A2—nephron tubule—focal segmental glomerulosclerosis	0.0278	0.0673	CbGeAlD
Amantadine—Muscle contractions involuntary—Cyclosporine—focal segmental glomerulosclerosis	0.0254	0.0603	CcSEcCtD
Amantadine—SLC22A2—kidney—focal segmental glomerulosclerosis	0.0244	0.0592	CbGeAlD
Amantadine—SLC22A2—cortex of kidney—focal segmental glomerulosclerosis	0.0238	0.0576	CbGeAlD
Amantadine—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.0209	0.0496	CcSEcCtD
Amantadine—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.0202	0.0479	CcSEcCtD
Amantadine—GRIN2A—Reelin signaling pathway—VLDLR—focal segmental glomerulosclerosis	0.0199	0.12	CbGpPWpGaD
Amantadine—SIGMAR1—nephron tubule—focal segmental glomerulosclerosis	0.0182	0.0439	CbGeAlD
Amantadine—MAOB—nephron tubule—focal segmental glomerulosclerosis	0.0174	0.0421	CbGeAlD
Amantadine—SLC22A1—kidney—focal segmental glomerulosclerosis	0.0173	0.0418	CbGeAlD
Amantadine—GRIN2B—Reelin signaling pathway—VLDLR—focal segmental glomerulosclerosis	0.0169	0.102	CbGpPWpGaD
Amantadine—SIGMAR1—cortex of kidney—focal segmental glomerulosclerosis	0.0155	0.0376	CbGeAlD
Amantadine—MAOB—kidney—focal segmental glomerulosclerosis	0.0153	0.037	CbGeAlD
Amantadine—MAOB—cortex of kidney—focal segmental glomerulosclerosis	0.0149	0.036	CbGeAlD
Amantadine—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.0142	0.0336	CcSEcCtD
Amantadine—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.0119	0.0281	CcSEcCtD
Amantadine—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.0119	0.0281	CcSEcCtD
Amantadine—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.0112	0.0266	CcSEcCtD
Amantadine—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0253	CcSEcCtD
Amantadine—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00998	0.0236	CcSEcCtD
Amantadine—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00993	0.0235	CcSEcCtD
Amantadine—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00962	0.0228	CcSEcCtD
Amantadine—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00942	0.0223	CcSEcCtD
Amantadine—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00914	0.0217	CcSEcCtD
Amantadine—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00911	0.0216	CcSEcCtD
Amantadine—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00892	0.0212	CcSEcCtD
Amantadine—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00885	0.021	CcSEcCtD
Amantadine—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00771	0.0183	CcSEcCtD
Amantadine—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00751	0.0178	CcSEcCtD
Amantadine—GRIN1—EPH-Ephrin signaling—MYH10—focal segmental glomerulosclerosis	0.00689	0.0418	CbGpPWpGaD
Amantadine—GRIN2B—EPH-Ephrin signaling—MYH10—focal segmental glomerulosclerosis	0.00672	0.0407	CbGpPWpGaD
Amantadine—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.00634	0.0153	CbGeAlD
Amantadine—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0061	0.0145	CcSEcCtD
Amantadine—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00605	0.0143	CcSEcCtD
Amantadine—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00595	0.0141	CcSEcCtD
Amantadine—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0056	0.0133	CcSEcCtD
Amantadine—ABCB1—kidney—focal segmental glomerulosclerosis	0.00557	0.0135	CbGeAlD
Amantadine—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00556	0.0132	CcSEcCtD
Amantadine—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00551	0.0131	CcSEcCtD
Amantadine—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00546	0.0129	CcSEcCtD
Amantadine—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.00542	0.0131	CbGeAlD
Amantadine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00541	0.0128	CcSEcCtD
Amantadine—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00537	0.0127	CcSEcCtD
Amantadine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00527	0.0125	CcSEcCtD
Amantadine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00522	0.0124	CcSEcCtD
Amantadine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00506	0.012	CcSEcCtD
Amantadine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00503	0.0119	CcSEcCtD
Amantadine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00494	0.0117	CcSEcCtD
Amantadine—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00481	0.0114	CcSEcCtD
Amantadine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00466	0.011	CcSEcCtD
Amantadine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00464	0.011	CcSEcCtD
Amantadine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00456	0.0108	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00454	0.0108	CcSEcCtD
Amantadine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00447	0.0106	CcSEcCtD
Amantadine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00442	0.0105	CcSEcCtD
Amantadine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00439	0.0104	CcSEcCtD
Amantadine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00439	0.0104	CcSEcCtD
Amantadine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0043	0.0102	CcSEcCtD
Amantadine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00426	0.0101	CcSEcCtD
Amantadine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00424	0.0101	CcSEcCtD
Amantadine—GRIN2C—Alzheimers Disease—GNAQ—focal segmental glomerulosclerosis	0.0042	0.0254	CbGpPWpGaD
Amantadine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00418	0.00991	CcSEcCtD
Amantadine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00397	0.0094	CcSEcCtD
Amantadine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00394	0.00934	CcSEcCtD
Amantadine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00391	0.00927	CcSEcCtD
Amantadine—GRIN1—Spinal Cord Injury—COL4A1—focal segmental glomerulosclerosis	0.00391	0.0237	CbGpPWpGaD
Amantadine—GRIN2D—Alzheimers Disease—GNAQ—focal segmental glomerulosclerosis	0.00391	0.0237	CbGpPWpGaD
Amantadine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.0039	0.00924	CcSEcCtD
Amantadine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00386	0.00915	CcSEcCtD
Amantadine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00381	0.00904	CcSEcCtD
Amantadine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00379	0.00898	CcSEcCtD
Amantadine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00378	0.00896	CcSEcCtD
Amantadine—GRIN1—EPH-Ephrin signaling—MYH9—focal segmental glomerulosclerosis	0.00378	0.0229	CbGpPWpGaD
Amantadine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00375	0.00889	CcSEcCtD
Amantadine—GRIN2B—EPH-Ephrin signaling—MYH9—focal segmental glomerulosclerosis	0.00368	0.0223	CbGpPWpGaD
Amantadine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.00857	CcSEcCtD
Amantadine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00347	0.00822	CcSEcCtD
Amantadine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00323	0.00766	CcSEcCtD
Amantadine—GRIN2A—Alzheimers Disease—GNAQ—focal segmental glomerulosclerosis	0.00321	0.0194	CbGpPWpGaD
Amantadine—GRIN2C—Alzheimers Disease—LPL—focal segmental glomerulosclerosis	0.00316	0.0191	CbGpPWpGaD
Amantadine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00315	0.00746	CcSEcCtD
Amantadine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.0031	0.00736	CcSEcCtD
Amantadine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.003	0.00711	CcSEcCtD
Amantadine—GRIN2D—Alzheimers Disease—LPL—focal segmental glomerulosclerosis	0.00294	0.0178	CbGpPWpGaD
Amantadine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.0029	0.00688	CcSEcCtD
Amantadine—GRIN1—Alzheimers Disease—GNAQ—focal segmental glomerulosclerosis	0.0028	0.0169	CbGpPWpGaD
Amantadine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00279	0.00661	CcSEcCtD
Amantadine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00277	0.00656	CcSEcCtD
Amantadine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.00655	CcSEcCtD
Amantadine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00275	0.00651	CcSEcCtD
Amantadine—GRIN2B—Alzheimers Disease—GNAQ—focal segmental glomerulosclerosis	0.00273	0.0165	CbGpPWpGaD
Amantadine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00261	0.00618	CcSEcCtD
Amantadine—GRIN1—Axon guidance—MYH10—focal segmental glomerulosclerosis	0.00256	0.0155	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—MYH10—focal segmental glomerulosclerosis	0.0025	0.0151	CbGpPWpGaD
Amantadine—GRIN2A—Alzheimers Disease—LPL—focal segmental glomerulosclerosis	0.00241	0.0146	CbGpPWpGaD
Amantadine—DDC—Dopaminergic Neurogenesis—TGFB1—focal segmental glomerulosclerosis	0.00221	0.0134	CbGpPWpGaD
Amantadine—GRIN1—Alzheimers Disease—LPL—focal segmental glomerulosclerosis	0.0021	0.0127	CbGpPWpGaD
Amantadine—GRIN2B—Alzheimers Disease—LPL—focal segmental glomerulosclerosis	0.00205	0.0124	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—COL4A4—focal segmental glomerulosclerosis	0.00189	0.0115	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—COL4A4—focal segmental glomerulosclerosis	0.00185	0.0112	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.00183	0.0111	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.00178	0.0108	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—COL4A1—focal segmental glomerulosclerosis	0.00174	0.0105	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—COL4A1—focal segmental glomerulosclerosis	0.0017	0.0103	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	0.00154	0.00934	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.00147	0.00891	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.00143	0.00869	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.0014	0.0085	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.00137	0.00829	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.00135	0.00819	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.00132	0.00798	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.00124	0.00753	CbGpPWpGaD
Amantadine—GRIN1—BDNF signaling pathway—SPP1—focal segmental glomerulosclerosis	0.00123	0.00747	CbGpPWpGaD
Amantadine—GRIN1—EPH-Ephrin signaling—MMP2—focal segmental glomerulosclerosis	0.00123	0.00743	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.00121	0.00734	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—SPP1—focal segmental glomerulosclerosis	0.0012	0.00728	CbGpPWpGaD
Amantadine—GRIN2B—EPH-Ephrin signaling—MMP2—focal segmental glomerulosclerosis	0.0012	0.00725	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.00119	0.00722	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00108	0.00655	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00105	0.00639	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00105	0.00636	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00102	0.0062	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.001	0.00607	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000976	0.00591	CbGpPWpGaD
Amantadine—GRIN1—EPH-Ephrin signaling—MMP9—focal segmental glomerulosclerosis	0.000923	0.00559	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.000906	0.00549	CbGpPWpGaD
Amantadine—GRIN2B—EPH-Ephrin signaling—MMP9—focal segmental glomerulosclerosis	0.000899	0.00545	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000821	0.00497	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.000772	0.00468	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	0.000769	0.00466	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.000763	0.00462	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.000753	0.00456	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	0.000727	0.0044	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	0.000711	0.00431	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.000638	0.00387	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	0.000634	0.00384	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	0.000609	0.00369	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	0.000608	0.00368	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.000592	0.00359	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000542	0.00328	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	0.000539	0.00326	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.000507	0.00307	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.000486	0.00294	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.000473	0.00287	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.000456	0.00276	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.000455	0.00276	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000454	0.00275	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.000445	0.00269	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00039	0.00236	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000386	0.00234	CbGpPWpGaD
Amantadine—DDC—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000368	0.00223	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.000357	0.00216	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.000345	0.00209	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000343	0.00208	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000341	0.00206	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000334	0.00202	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000331	0.002	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000325	0.00197	CbGpPWpGaD
Amantadine—DDC—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000324	0.00196	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000318	0.00192	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000317	0.00192	CbGpPWpGaD
Amantadine—MAOB—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00031	0.00188	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.000301	0.00182	CbGpPWpGaD
Amantadine—DDC—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000299	0.00181	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000297	0.0018	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000277	0.00168	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000275	0.00166	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000274	0.00166	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000273	0.00165	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000258	0.00156	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000252	0.00153	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000251	0.00152	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	0.000248	0.0015	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000245	0.00148	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000238	0.00144	CbGpPWpGaD
Amantadine—DDC—Metabolism—LPL—focal segmental glomerulosclerosis	0.000225	0.00136	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00022	0.00133	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000218	0.00132	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000209	0.00127	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000206	0.00125	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000202	0.00122	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000199	0.00121	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000198	0.0012	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000197	0.00119	CbGpPWpGaD
Amantadine—DDC—Metabolism—AGT—focal segmental glomerulosclerosis	0.000192	0.00116	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00019	0.00115	CbGpPWpGaD
Amantadine—MAOB—Metabolism—LPL—focal segmental glomerulosclerosis	0.000189	0.00115	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000186	0.00113	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000184	0.00111	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000168	0.00102	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000167	0.00101	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000165	0.000996	CbGpPWpGaD
Amantadine—MAOB—Metabolism—AGT—focal segmental glomerulosclerosis	0.000162	0.00098	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00016	0.00097	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000153	0.000929	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000152	0.000923	CbGpPWpGaD
Amantadine—DDC—Metabolism—ALB—focal segmental glomerulosclerosis	0.000148	0.000894	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000145	0.000877	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000142	0.000862	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000141	0.000852	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000135	0.000818	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000133	0.000808	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000131	0.000794	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000129	0.000783	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000124	0.000753	CbGpPWpGaD
Amantadine—MAOB—Metabolism—ALB—focal segmental glomerulosclerosis	0.000124	0.000752	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000122	0.000742	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000118	0.000716	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000118	0.000714	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000117	0.000709	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000107	0.00065	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—LPL—focal segmental glomerulosclerosis	0.0001	0.000608	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.85e-05	0.000596	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—LPL—focal segmental glomerulosclerosis	9.36e-05	0.000567	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	9.01e-05	0.000546	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	8.99e-05	0.000544	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—AGT—focal segmental glomerulosclerosis	8.59e-05	0.00052	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—AGT—focal segmental glomerulosclerosis	8.01e-05	0.000485	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	7.91e-05	0.000479	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	7.69e-05	0.000466	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.64e-05	0.000462	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.41e-05	0.000449	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.29e-05	0.000442	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.02e-05	0.000425	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ALB—focal segmental glomerulosclerosis	6.59e-05	0.000399	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.34e-05	0.000384	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ALB—focal segmental glomerulosclerosis	6.14e-05	0.000372	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.86e-05	0.000355	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	5.48e-05	0.000332	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.87e-05	0.000295	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	4.69e-05	0.000284	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.73e-05	0.000226	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	3.6e-05	0.000218	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.08e-05	0.000186	CbGpPWpGaD
